
James Vannucci
Examiner (ID: 2449)
| Most Active Art Unit | 2821 |
| Art Unit(s) | 2821, 2828 |
| Total Applications | 788 |
| Issued Applications | 682 |
| Pending Applications | 52 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20092140
[patent_doc_number] => 20250222076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => USE OF p55gamma PROTEIN OR ENCODING GENE THEREOF AS TARGET IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING VASCULAR CALCIFICATION
[patent_app_type] => utility
[patent_app_number] => 18/764595
[patent_app_country] => US
[patent_app_date] => 2024-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764595
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/764595 | USE OF p55gamma PROTEIN OR ENCODING GENE THEREOF AS TARGET IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING VASCULAR CALCIFICATION | Jul 4, 2024 | Pending |
Array
(
[id] => 19387922
[patent_doc_number] => 20240277792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => ONCOLYTIC VIRUSES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/653847
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653847 | ONCOLYTIC VIRUSES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER | May 1, 2024 | Pending |
Array
(
[id] => 19389744
[patent_doc_number] => 20240279614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHOD FOR CRYOPRESERVATION AND RESUSCITATION OF FOLLICLES
[patent_app_type] => utility
[patent_app_number] => 18/652960
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652960 | METHOD FOR CRYOPRESERVATION AND RESUSCITATION OF FOLLICLES | May 1, 2024 | Pending |
Array
(
[id] => 19125005
[patent_doc_number] => 20240130358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => ORGAN PERFUSION AND PRESERVATION SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 18/403061
[patent_app_country] => US
[patent_app_date] => 2024-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18403061
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/403061 | ORGAN PERFUSION AND PRESERVATION SYSTEM AND METHOD | Jan 2, 2024 | Pending |
Array
(
[id] => 19332804
[patent_doc_number] => 20240247234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => OFF-THE-SHELF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/401238
[patent_app_country] => US
[patent_app_date] => 2023-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18401238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/401238 | OFF-THE-SHELF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS AND PREPARATION METHOD AND USE THEREOF | Dec 28, 2023 | Pending |
Array
(
[id] => 19189007
[patent_doc_number] => 20240167920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITION AND METHOD FOR THREE-DIMENSIONAL HISTOLOGICAL STAINING
[patent_app_type] => utility
[patent_app_number] => 18/510652
[patent_app_country] => US
[patent_app_date] => 2023-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18510652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/510652 | COMPOSITION AND METHOD FOR THREE-DIMENSIONAL HISTOLOGICAL STAINING | Nov 15, 2023 | Pending |
Array
(
[id] => 19098064
[patent_doc_number] => 20240117292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => 3D BIOPHOTONIC DEVICES FOR OPTICAL ELECTROPHYSIOLOGY AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/509951
[patent_app_country] => US
[patent_app_date] => 2023-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18509951
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/509951 | 3D BIOPHOTONIC DEVICES FOR OPTICAL ELECTROPHYSIOLOGY AND METHODS OF USE THEREOF | Nov 14, 2023 | Pending |
Array
(
[id] => 19343578
[patent_doc_number] => 20240252541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => METHODS OF CELL THERAPIES
[patent_app_type] => utility
[patent_app_number] => 18/357976
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357976
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357976 | METHODS OF CELL THERAPIES | Jul 23, 2023 | Pending |
Array
(
[id] => 18862326
[patent_doc_number] => 20230416762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => RECOMBINANT PLASMID FOR MANUFACTURING BIO-BASED MATERIALS
[patent_app_type] => utility
[patent_app_number] => 18/209726
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18209726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/209726 | RECOMBINANT PLASMID FOR MANUFACTURING BIO-BASED MATERIALS | Jun 13, 2023 | Pending |
Array
(
[id] => 18972276
[patent_doc_number] => 20240052368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => GENERATION OF NEXT GENERATION RECOMBINANT AAV GENE THERAPY VECTORS THAT ADOPT 3D CONFORMATION
[patent_app_type] => utility
[patent_app_number] => 18/332380
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18332380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/332380 | GENERATION OF NEXT GENERATION RECOMBINANT AAV GENE THERAPY VECTORS THAT ADOPT 3D CONFORMATION | Jun 8, 2023 | Pending |
Array
(
[id] => 18844850
[patent_doc_number] => 20230407254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => INDUCIBLE PLURIPOTENT STEM CELL DERIVED REGENERATIVE T CELLS
[patent_app_type] => utility
[patent_app_number] => 18/331098
[patent_app_country] => US
[patent_app_date] => 2023-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331098
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331098 | INDUCIBLE PLURIPOTENT STEM CELL DERIVED REGENERATIVE T CELLS | Jun 6, 2023 | Pending |
Array
(
[id] => 18818779
[patent_doc_number] => 20230393119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood
[patent_app_type] => utility
[patent_app_number] => 18/328967
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328967
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/328967 | Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood | Jun 4, 2023 | Pending |
Array
(
[id] => 18844861
[patent_doc_number] => 20230407265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITION AND METHODS FOR 3D CULTURE OF ISLET CELLS
[patent_app_type] => utility
[patent_app_number] => 18/320106
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320106 | COMPOSITION AND METHODS FOR 3D CULTURE OF ISLET CELLS | May 17, 2023 | Pending |
Array
(
[id] => 18769394
[patent_doc_number] => 20230364156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/318305
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318305 | TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS | May 15, 2023 | Pending |
Array
(
[id] => 18769382
[patent_doc_number] => 20230364143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/311464
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311464 | PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION | May 2, 2023 | Pending |
Array
(
[id] => 18726161
[patent_doc_number] => 20230340417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => DEFINED MATRIX FOR THE DIFFERENTIATION OF ISLETS
[patent_app_type] => utility
[patent_app_number] => 18/137267
[patent_app_country] => US
[patent_app_date] => 2023-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18137267
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/137267 | DEFINED MATRIX FOR THE DIFFERENTIATION OF ISLETS | Apr 19, 2023 | Pending |
Array
(
[id] => 19203140
[patent_doc_number] => 20240175039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => ENGINEERING PROBIOTIC FOR DEGRADING URIC ACID, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/556678
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556678 | ENGINEERING PROBIOTIC FOR DEGRADING URIC ACID, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF | Mar 6, 2023 | Pending |
Array
(
[id] => 19768530
[patent_doc_number] => 20250049956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => IN VIVO REPROGRAMMING OF PHOTORECEPTOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/721144
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721144
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721144 | IN VIVO REPROGRAMMING OF PHOTORECEPTOR CELLS | Dec 21, 2022 | Pending |
Array
(
[id] => 19770303
[patent_doc_number] => 20250051729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => METHOD FOR PREPARING HIGHLY DIFFERENTIATED KIDNEY ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 18/719518
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719518
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719518 | METHOD FOR PREPARING HIGHLY DIFFERENTIATED KIDNEY ORGANOIDS | Oct 23, 2022 | Pending |
Array
(
[id] => 19615306
[patent_doc_number] => 20240400986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => MEMBRANE BOUND COMPOSITIONS AND METHODS RELATING TO SAME
[patent_app_type] => utility
[patent_app_number] => 18/690845
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690845
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690845 | MEMBRANE BOUND COMPOSITIONS AND METHODS RELATING TO SAME | Sep 14, 2022 | Pending |